Establishment and validation of an integrated traditional Chinese and Western medicine risk prediction model for aromatase inhibitor-related bone loss in breast cancer patients

CHU Meiling; YANG Guanghua; YIN Yulian; CHEN Zongxin; ZHAO Bin; CHEN Hongfeng

doi:10.88888/j.1673-1727.2026.4.1227-1234

CHU Meiling, YANG Guanghua, YIN Yulian, CHEN Zongxin, ZHAO Bin, CHEN Hongfeng

China Journal of Traditional Chinese Medicine and Pharmacy ›› 2026, Vol. 41 ›› Issue (4) : 1227-1234.

PDF(5374 KB)

China Journal of Traditional Chinese Medicine and Pharmacy ›› 2026, Vol. 41 ›› Issue (4) : 1227-1234. DOI: 10.88888/j.1673-1727.2026.4.1227-1234

Research Paper

Establishment and validation of an integrated traditional Chinese and Western medicine risk prediction model for aromatase inhibitor-related bone loss in breast cancer patients

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 41(4): 1227-1234 https://doi.org/10.88888/j.1673-1727.2026.4.1227-1234

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(5374 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2024-10-08	2026-04-01
Issue Date
2026-05-12

Please choose a citation manager

Content to export